Skip to main content
Top
Published in: Journal of Nanoparticle Research 10/2011

01-10-2011 | Research Paper

Investigation of in vitro efficiency of magnetic nanoparticle-conjugated 125I-uracil glucuronides in adenocarcinoma cells

Published in: Journal of Nanoparticle Research | Issue 10/2011

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Modification of the magnetic properties of a drug can be used to direct the drug to the desired site, enhancing its therapeutic effectiveness and reducing side effects. In this study, surface-modified magnetic nanoparticles were immobilized with uracil glucuronide derivatives and then labeled with I-125. The morphology, structure, and composition of the magnetic particles were examined by TEM, SEM, VSM, and XRD. The particles sizes were about 50 nm. The labeling yield was 93.8% for uracil-O-glucuronide-immobilized magnetic particles and 95.0% for uracil-N-glucuronide-immobilized magnetic particles. The cell incorporation rates of N- and O-glucuronides were higher than those of uracil. The incorporation rates of uracil-, O-glucuronide-, and N-glucuronide-conjugated magnetic particles were all high. The cell incorporation rates of ligand-conjugated magnetic particles increased under a magnetic field.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Appendix
Available only for authorised users
Literature
go back to reference Alexiou C, Bergemann C, Schmid R, Hulin P, Schmidt A, Jurgons R, Arnold W, Parak FG (2002) Enrichment and biodistribution of a magnetically targeted drug carrier. Eur Cell Mater 3:135–137 Alexiou C, Bergemann C, Schmid R, Hulin P, Schmidt A, Jurgons R, Arnold W, Parak FG (2002) Enrichment and biodistribution of a magnetically targeted drug carrier. Eur Cell Mater 3:135–137
go back to reference Alkharfy KM, Frye RF (2002) Sensitive liquid chromatographic method using fluorescence detection for the determination of estradiol 3- and 17-glucuronides in rat and human liver microsomal incubations: formation kinetics. J Chromatogr B Analyt Technol Biomed Life Sci 774:33–38CrossRef Alkharfy KM, Frye RF (2002) Sensitive liquid chromatographic method using fluorescence detection for the determination of estradiol 3- and 17-glucuronides in rat and human liver microsomal incubations: formation kinetics. J Chromatogr B Analyt Technol Biomed Life Sci 774:33–38CrossRef
go back to reference Asmatulua R, Zalichb MA, Clausa RO, Riffleb JS (2005) Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. J Magn Magn Mater 292:108–119CrossRef Asmatulua R, Zalichb MA, Clausa RO, Riffleb JS (2005) Synthesis, characterization and targeting of biodegradable magnetic nanocomposite particles by external magnetic fields. J Magn Magn Mater 292:108–119CrossRef
go back to reference Berry CC, Curtis ASG (2003) Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 36:198–206CrossRef Berry CC, Curtis ASG (2003) Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D Appl Phys 36:198–206CrossRef
go back to reference Biber FZ, Unak P, Ertay T, Medine EI, Zihnioglu F, Tasci C, Durak H (2006) Synthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential. Appl Radiat Isot 64:778–788CrossRef Biber FZ, Unak P, Ertay T, Medine EI, Zihnioglu F, Tasci C, Durak H (2006) Synthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential. Appl Radiat Isot 64:778–788CrossRef
go back to reference Bock KW, Kohle C (2009) Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions. Biochem Pharmacol 77:1458–1465CrossRef Bock KW, Kohle C (2009) Topological aspects of oligomeric UDP-glucuronosyltransferases in endoplasmic reticulum membranes: advances and open questions. Biochem Pharmacol 77:1458–1465CrossRef
go back to reference Cao J, Wang Y, Yu J, Xia J, Zhang C, Yin D, Hafeli UO (2004) Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J Magn Magn Mater 277:165–174CrossRef Cao J, Wang Y, Yu J, Xia J, Zhang C, Yin D, Hafeli UO (2004) Preparation and radiolabeling of surface-modified magnetic nanoparticles with rhenium-188 for magnetic targeted radiotherapy. J Magn Magn Mater 277:165–174CrossRef
go back to reference Charlton DE, Booz J (1981) A Monte Carlo treatment of the decay of I-125. Radiat Res 87:10–23CrossRef Charlton DE, Booz J (1981) A Monte Carlo treatment of the decay of I-125. Radiat Res 87:10–23CrossRef
go back to reference Chen KC, Cheng TL, Leu YL, Prijovich ZM, Chuang CH, Chen BM, Roffler SR (2007) Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes. Cancer Gene Ther 14:187–200CrossRef Chen KC, Cheng TL, Leu YL, Prijovich ZM, Chuang CH, Chen BM, Roffler SR (2007) Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes. Cancer Gene Ther 14:187–200CrossRef
go back to reference Chunfua Z, Jinquana C, Duanzhia Y, Yongxiana W, Yanlinb F, Jiaju T (2004) Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy. Appl Radiat Isot 61:1255–1259CrossRef Chunfua Z, Jinquana C, Duanzhia Y, Yongxiana W, Yanlinb F, Jiaju T (2004) Preparation and radiolabeling of human serum albumin (HSA)-coated magnetite nanoparticles for magnetically targeted therapy. Appl Radiat Isot 61:1255–1259CrossRef
go back to reference Dagdeviren K, Ünak P, Bekis R, Müftüler FZB, Ertay T, Ulker O, Durak H (2007) Radioiodinated magnetic targeted carriers (I-131-MTC). J Radioanal Nucl Chem 273:635–639CrossRef Dagdeviren K, Ünak P, Bekis R, Müftüler FZB, Ertay T, Ulker O, Durak H (2007) Radioiodinated magnetic targeted carriers (I-131-MTC). J Radioanal Nucl Chem 273:635–639CrossRef
go back to reference David ES, Ulrike H (1999) Optimization of β-D-glucuronide synthesis using UDP-glucuronyl transferase. Enzyme Microb Technol 24:388–396CrossRef David ES, Ulrike H (1999) Optimization of β-D-glucuronide synthesis using UDP-glucuronyl transferase. Enzyme Microb Technol 24:388–396CrossRef
go back to reference Enginar H, Unak P, Lambrecht FY, Biber FZ, Medine EI, Cetinkaya B (2005) Synthesis of 131I labeled estrone derivatives and biodistribution studies on rats. J Radioanal Nucl Chem 264:535–539CrossRef Enginar H, Unak P, Lambrecht FY, Biber FZ, Medine EI, Cetinkaya B (2005) Synthesis of 131I labeled estrone derivatives and biodistribution studies on rats. J Radioanal Nucl Chem 264:535–539CrossRef
go back to reference Ertay T, Ünak P, Özdogan O, Biber FZ, Zihnioglu F, Medine EI, Durak H (2006) 99mTc-Exorphin-glucuronide in tumor diagnosis: preparation and biodistribution studies in rats. J Radioanal Nucl Chem 269:21–28CrossRef Ertay T, Ünak P, Özdogan O, Biber FZ, Zihnioglu F, Medine EI, Durak H (2006) 99mTc-Exorphin-glucuronide in tumor diagnosis: preparation and biodistribution studies in rats. J Radioanal Nucl Chem 269:21–28CrossRef
go back to reference Felinto MCFC, Parra DF, Lugao AB, Batista MP, Higa OZ, Yamaura M, Camilo RL, Ribela MTCP, Sampaio LC (2005) Magnetic polymeric microspheres for protein adsorption. Nucl Instrum Methods Phys Res B 236:495–500CrossRef Felinto MCFC, Parra DF, Lugao AB, Batista MP, Higa OZ, Yamaura M, Camilo RL, Ribela MTCP, Sampaio LC (2005) Magnetic polymeric microspheres for protein adsorption. Nucl Instrum Methods Phys Res B 236:495–500CrossRef
go back to reference Franklin TJ, Jacobs V, Jones G, Ple P, Bruneau P (1996) Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Cancer Res 56:984–987 Franklin TJ, Jacobs V, Jones G, Ple P, Bruneau P (1996) Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Cancer Res 56:984–987
go back to reference Gu FX, Karnik R, Wang AZ, Alexis F, Levy-Nissenbaum E, Hong S, Langer RS, Farokhzad OC (2007) Targeted nanoparticles for cancer therapy. Nanotoday June:14–21 Gu FX, Karnik R, Wang AZ, Alexis F, Levy-Nissenbaum E, Hong S, Langer RS, Farokhzad OC (2007) Targeted nanoparticles for cancer therapy. Nanotoday June:14–21
go back to reference Hafeli UO (2004) Magnetically modulated therapeutic systems. Int J Pharm 277:19–24CrossRef Hafeli UO (2004) Magnetically modulated therapeutic systems. Int J Pharm 277:19–24CrossRef
go back to reference Hafeli UO, Sweeney SM, Beresford BA, Humm JL, Macklis RM (1995) Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results. Nucl Med Biol 22:147–155CrossRef Hafeli UO, Sweeney SM, Beresford BA, Humm JL, Macklis RM (1995) Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results. Nucl Med Biol 22:147–155CrossRef
go back to reference Hafeli U, Pauer G, Failing S, Tapolsky G (2001) Radiolabeling of magnetic particles with rhenium-188 for cancer therapy. J Magn Magn Mater 225:73–78CrossRef Hafeli U, Pauer G, Failing S, Tapolsky G (2001) Radiolabeling of magnetic particles with rhenium-188 for cancer therapy. J Magn Magn Mater 225:73–78CrossRef
go back to reference Hafeli UO, Yu J, Farudi F, Li Y, Tapolsky G (2003) Radiolabeling of magnetic targeted carriers (MTC) with indium-111. Nucl Med Biol 30:761–769CrossRef Hafeli UO, Yu J, Farudi F, Li Y, Tapolsky G (2003) Radiolabeling of magnetic targeted carriers (MTC) with indium-111. Nucl Med Biol 30:761–769CrossRef
go back to reference Hong RY, Li JH, Zhang SZ, Li HZ, Zheng Y, Ding JM, Wei DG (2009) Preparation and characterization of silica-coated Fe3O4 nanoparticles used as precursor of ferrofluids. Appl Surf Sci 255:3485–3492CrossRef Hong RY, Li JH, Zhang SZ, Li HZ, Zheng Y, Ding JM, Wei DG (2009) Preparation and characterization of silica-coated Fe3O4 nanoparticles used as precursor of ferrofluids. Appl Surf Sci 255:3485–3492CrossRef
go back to reference LaConte L, Nitin N, Bao G (2005) Magnetic nanoparticle probes. Nanotoday May:32–38 LaConte L, Nitin N, Bao G (2005) Magnetic nanoparticle probes. Nanotoday May:32–38
go back to reference Lei Z, Li Y, Wei X (2008) A facile two-step modifying process for preparation of poly(SStNa)-grafted Fe3O4/SiO2 particles. J Solid State Chem 181:480–486CrossRef Lei Z, Li Y, Wei X (2008) A facile two-step modifying process for preparation of poly(SStNa)-grafted Fe3O4/SiO2 particles. J Solid State Chem 181:480–486CrossRef
go back to reference Liang S, Wang Y, Yu J, Zhang C, Xia J, Yin D (2007) Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J Mater Sci Mater Med 18:2297–2302CrossRef Liang S, Wang Y, Yu J, Zhang C, Xia J, Yin D (2007) Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J Mater Sci Mater Med 18:2297–2302CrossRef
go back to reference Liu X, Guan Y, Yang Y, Ma Z, Wu X, Liu H (2004a) Preparation of superparamagnetic immunomicrospheres and application for antibody purification. J Appl Polym Sci 94:2205–2211CrossRef Liu X, Guan Y, Yang Y, Ma Z, Wu X, Liu H (2004a) Preparation of superparamagnetic immunomicrospheres and application for antibody purification. J Appl Polym Sci 94:2205–2211CrossRef
go back to reference Liu X, Ma Z, Xing J, Liu H (2004b) Preparation and characterization of amino-silane modified superparamagnetic silica nanospheres. J Magn Magn Mater 270:1–6CrossRef Liu X, Ma Z, Xing J, Liu H (2004b) Preparation and characterization of amino-silane modified superparamagnetic silica nanospheres. J Magn Magn Mater 270:1–6CrossRef
go back to reference Liu X, Xing J, Guan Y, Shan G, Liu H (2004c) Synthesis of amino-silane modified superparamagnetic silica supports and their use for protein immobilization. Colloids Surf A: Physicochem Eng Asp 238:127–131CrossRef Liu X, Xing J, Guan Y, Shan G, Liu H (2004c) Synthesis of amino-silane modified superparamagnetic silica supports and their use for protein immobilization. Colloids Surf A: Physicochem Eng Asp 238:127–131CrossRef
go back to reference Liu X, Kaminski MD, Guan Y, Chen H, Liuc H, Rosengart AJ (2006) Preparation and characterization of hydrophobic superparamagnetic magnetite gel. J Magn Magn Mater 306:248–253CrossRef Liu X, Kaminski MD, Guan Y, Chen H, Liuc H, Rosengart AJ (2006) Preparation and characterization of hydrophobic superparamagnetic magnetite gel. J Magn Magn Mater 306:248–253CrossRef
go back to reference Lubbe AS, Alexiou C, Bergemann C (2001) Clinical applications of magnetic drug targeting. J Surg Res 95:200–206CrossRef Lubbe AS, Alexiou C, Bergemann C (2001) Clinical applications of magnetic drug targeting. J Surg Res 95:200–206CrossRef
go back to reference Nara M, Torii H, Tasumi M (1996) Correlation between the vibrational frequencies of the carboxylate group and the types of its coordination to a metal ion: an ab initio molecular orbital study. J Phys Chem 100:19812–19817CrossRef Nara M, Torii H, Tasumi M (1996) Correlation between the vibrational frequencies of the carboxylate group and the types of its coordination to a metal ion: an ab initio molecular orbital study. J Phys Chem 100:19812–19817CrossRef
go back to reference Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36:167–181CrossRef Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 36:167–181CrossRef
go back to reference Ramanujan RV, Chong WT (2004) The synthesis and characterization of polymer coated iron oxide microspheres. J Mater Sci Mater Med 15:901–908CrossRef Ramanujan RV, Chong WT (2004) The synthesis and characterization of polymer coated iron oxide microspheres. J Mater Sci Mater Med 15:901–908CrossRef
go back to reference Rudge SR, Kurtz TL, Vessely CR, Catterall LG, Williamson DL (2000) Preparation, characterization, and performance of magnetic iron–carbon composite microparticles for chemotherapy. Biomaterials 21:1411–1420CrossRef Rudge SR, Kurtz TL, Vessely CR, Catterall LG, Williamson DL (2000) Preparation, characterization, and performance of magnetic iron–carbon composite microparticles for chemotherapy. Biomaterials 21:1411–1420CrossRef
go back to reference Saiyed ZM, Telang SD, Ramchand CN (2003) Application of magnetic techniques in the field of drug discovery and biomedicine. Biomagn Res Technol 1:1–8 Saiyed ZM, Telang SD, Ramchand CN (2003) Application of magnetic techniques in the field of drug discovery and biomedicine. Biomagn Res Technol 1:1–8
go back to reference Semnani ES, Wang K, Adelstein SJ, Kassis AI (2005) 5-[123I/125I]iodo-2’-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting. J Nucl Med 46:800–806 Semnani ES, Wang K, Adelstein SJ, Kassis AI (2005) 5-[123I/125I]iodo-2’-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting. J Nucl Med 46:800–806
go back to reference Unak T, Unak P (1993) Synkavit and its direct labelling with iodine-125, as a potential anti-cancer drug. Nucl Med Biol 20:889–894CrossRef Unak T, Unak P (1993) Synkavit and its direct labelling with iodine-125, as a potential anti-cancer drug. Nucl Med Biol 20:889–894CrossRef
go back to reference Wunderlich G, Drews A, Kotzerke J (2005) A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine. Appl Radiat Isot 62:915–918CrossRef Wunderlich G, Drews A, Kotzerke J (2005) A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine. Appl Radiat Isot 62:915–918CrossRef
go back to reference Xu H, Tong N, Cui L, Lu Y, Gu H (2007) Preparation of hydrophilic magnetic nanospheres with high saturation magnetization. J Magn Magn Mater 311:125–130 Xu H, Tong N, Cui L, Lu Y, Gu H (2007) Preparation of hydrophilic magnetic nanospheres with high saturation magnetization. J Magn Magn Mater 311:125–130
go back to reference Zihnioglu F (1992) Isolation, purification and immobilization of UDP-glucuronyl transpherase. In Graduate School of Natural and Applied Sciences, Chemistry Department, Biochemistry Section (Bornova, Izmir, Ege University), p 169 Zihnioglu F (1992) Isolation, purification and immobilization of UDP-glucuronyl transpherase. In Graduate School of Natural and Applied Sciences, Chemistry Department, Biochemistry Section (Bornova, Izmir, Ege University), p 169
Metadata
Title
Investigation of in vitro efficiency of magnetic nanoparticle-conjugated 125I-uracil glucuronides in adenocarcinoma cells
Publication date
01-10-2011
Published in
Journal of Nanoparticle Research / Issue 10/2011
Print ISSN: 1388-0764
Electronic ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-011-0436-6

Other articles of this Issue 10/2011

Journal of Nanoparticle Research 10/2011 Go to the issue

Premium Partners